A generic approach to engineer antibody pH-switches using combinatorial histidine scanning libraries and yeast display |
| |
Authors: | Christian Schr?ter Ralf Günther Laura Rhiel Stefan Becker Lars Toleikis Achim Doerner Janine Becker Andreas Sch?nemann Daichi Nasu Berend Neuteboom Harald Kolmar Bj?rn Hock |
| |
Affiliation: | 1.Institute for Organic Chemistry and Biochemistry; Technische Universität Darmstadt; Darmstadt, Germany;2.Protein Engineering and Antibody Technologies; Merck-Serono; Merck KGaA; Darmstadt, Germany;3.EMD Serono Research Center, Inc.; Billerica, MA USA |
| |
Abstract: | There is growing interest in the fast and robust engineering of protein pH-sensitivity that aims to reduce binding at acidic pH, compared to neutral pH. Here, we describe a novel strategy for the incorporation of pH-sensitive antigen binding functions into antibody variable domains using combinatorial histidine scanning libraries and yeast surface display. The strategy allows simultaneous screening for both, high affinity binding at pH 7.4 and pH-sensitivity, and excludes conventional negative selection steps. As proof of concept, we applied this strategy to incorporate pH-dependent antigen binding into the complementary-determining regions of adalimumab. After 3 consecutive rounds of separate heavy and light chain library screening, pH-sensitive variants could be isolated. Heavy and light chain mutations were combined, resulting in 3 full-length antibody variants that revealed sharp, reversible pH-dependent binding profiles. Dissociation rate constants at pH 6.0 increased 230- to 780-fold, while high affinity binding at pH 7.4 in the sub-nanomolar range was retained. Furthermore, binding to huFcRn and thermal stability were not affected by histidine substitutions. Overall, this study emphasizes a generalizable strategy for engineering pH-switch functions potentially applicable to a variety of antibodies and further proteins-based therapeutics. |
| |
Keywords: | Yeast surface display Fab display antibody engineering protein engineering pH-dependent antigen binding pH-switch adalimumab |
|
|